Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose intradermal IPV by jet injector versus standard intramuscular IPV booster in healthy adults
NL-OMON32437Phase 2Active, not recruiting
- Sponsor
- Nederlands Vaccin Instituut
- Start
- Aug 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of trivalent inactivated polio vaccine in poliomyelitis (4 arms), sponsored by Nederlands Vaccin Instituut. Primary endpoints: Neutralizing antibody levels in serum, Local adverse reactions and 1 more. Started Aug 2010; status: active, not recruiting.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NL-OMON32437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32437.